T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHK
1401
DELISTED
Chesapeake Energy Corporation
CHK
| $4.45M | ﹤0.01% |
5,197
+975
| +23% | +$936K |
|
1402
ON Semiconductor
ON
$31.8B
| $4.4M | ﹤0.01% |
499,325
+18,667
| +4% | +$178K |
|
|
ACOR
1403
DELISTED
Acorda Therapeutics
ACOR
| $4.39M | ﹤0.01% |
1,435
-4
| -0.3% | -$13K |
|
|
STAY
1404
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $4.36M | ﹤0.01% |
291,823
+4,500
| +2% | +$67.7K |
|
1405
Natera
NTRA
$44.8B
| $4.36M | ﹤0.01% |
+361,223
| New | +$4.02M |
|
|
GXP
1406
DELISTED
Great Plains Energy Incorporated
GXP
| $4.35M | ﹤0.01% |
143,100
+9,722
| +7% | +$298K |
|
1407
Cadence Design Systems
CDNS
$89.2B
| $4.33M | ﹤0.01% |
178,151
-63
| -0% | -$1.51K |
|
1408
Innoviva
INVA
$1.5B
| $4.32M | ﹤0.01% |
409,934
+900
| +0.2% | +$10.6K |
|
|
CTWS
1409
DELISTED
Connecticut Water Service Inc
CTWS
| $4.31M | ﹤0.01% |
76,673
+66,493
| +653% | +$3.24M |
|
1410
Herc Holdings
HRI
$5.64B
| $4.29M | ﹤0.01% |
129,230
+3,850
| +3% | +$111K |
|
|
WSTC
1411
DELISTED
West Corporation
WSTC
| $4.28M | ﹤0.01% |
217,530
+4,600
| +2% | +$98.7K |
|
|
GNMX
1412
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $4.22M | ﹤0.01% |
761,200
-3,800
| -0.5% | -$20K |
|
1413
Monolithic Power Systems
MPWR
$67B
| $4.19M | ﹤0.01% |
61,310
+1,610
| +3% | +$105K |
|
|
CDK
1414
DELISTED
CDK Global, Inc.
CDK
| $4.13M | ﹤0.01% |
74,397
-6,188
| -8% | -$320K |
|
1415
Urban Outfitters
URBN
$6.53B
| $4.09M | ﹤0.01% |
148,650
-3,220
| -2% | -$92.5K |
|
1416
BHP
BHP
$222B
| $4.01M | ﹤0.01% |
157,388
+2,242
| +1% | +$55.9K |
|
|
SRT
1417
DELISTED
Startek Inc.
SRT
| $4.01M | ﹤0.01% |
917,350
| – | – |
|
1418
HubSpot
HUBS
$12B
| $3.94M | ﹤0.01% |
+90,631
| New | +$4.11M |
|
|
CUDA
1419
DELISTED
Barracuda Networks, Inc.
CUDA
| $3.93M | ﹤0.01% |
259,376
+140,293
| +118% | +$2.24M |
|
1420
Babcock & Wilcox
BW
$1.39B
| $3.92M | ﹤0.01% |
26,683
+17,968
| +206% | +$3.83M |
|
1421
WisdomTree
WT
$3.44B
| $3.86M | ﹤0.01% |
394,700
-189,698
| -32% | -$2.09M |
|
1422
Hyster-Yale Materials Handling
HY
$617M
| $3.81M | ﹤0.01% |
64,014
-7,900
| -11% | -$496K |
|
|
WPG
1423
DELISTED
Washington Prime Group Inc.
WPG
| $3.8M | ﹤0.01% |
37,760
+6,966
| +23% | +$652K |
|
1424
Cohu
COHU
$2.76B
| $3.74M | ﹤0.01% |
344,482
-18
| -0% | -$207 |
|
|
FIT
1425
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $3.73M | ﹤0.01% |
+305,536
| New | +$4.52M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.